After the 6-week randomized and double-blind trial with 290 MDD patients, they found no statistical differences for the SLC6A3 3′UTR VNTR polymorphism between responders and non-responders (p > 0.05). This evidence concerns the gene SLC6A3 and major depressive disorder.